About Sensible Biotechnologies
Sensible Biotechnologies is a biotechnology company that develops cell-based technologies for the design of mRNA therapeutics.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Oxford, United Kingdom
Year Founded
2021
Team Size
55 employees
Tracked Since
Sep 28, 2026
Web & Domain Identity
Official Website
sensible.bio
Domain Registered Date
Aug 9, 2021
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $47,000,000 · Series-A
firstwordpharma.com
- Capital Raise
Raised $4,200,000 · Pre-Seed
- Milestone
X account created (@sensible_bio)
352 followers
- Milestone
Website domain registered
sensible.bio
- Milestone
Company founded
Oxford, United Kingdom
Investors & Backers
BACKED VC
BlueYard Capital
Christoph Huber
Civilization Ventures
European Union
Florian Schuster
Government of Slovenia
IQT
Isomer Capital
Jason Foster
KAYA
OTB Ventures
Oxford Science Enterprises
Possible Ventures
Recode Health Ventures
Springboard Health Angels
Timothy Garnett
Y Combinator
ZAKA VC
Funding History
Series-A
· Oct 6, 2026
$47,000,000 firstwordpharma.com
Pre-Seed
· Apr 6, 2023
$4,200,000 Source
Venture Round
· Undisclosed
Undisclosed Source
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026